Profile
Oren Isacoff worked as a Director at Checkmate Pharmaceuticals, Inc. from 2019 to 2022 and as a Senior Associate at TPG Special Situations Partners LLC in 2014-2015.
He completed his undergraduate degree at the University of Pennsylvania in 2006 and his graduate degree at The Wharton School of the University of Pennsylvania in 2013.
Former positions of Oren Isacoff
| Companies | Position | End |
|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Director/Board Member | 30/05/2022 |
TPG Special Situations Partners LLC
 TPG Special Situations Partners LLC Finance/Rental/LeasingFinance TPG Special Situations Partners LLC provides financial services. The company is headquartered in Fort Worth, TX. | Corporate Officer/Principal | 30/04/2015 |
Training of Oren Isacoff
| The Wharton School of the University of Pennsylvania | Graduate Degree |
| University of Pennsylvania | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
TPG Special Situations Partners LLC
TPG Special Situations Partners LLC Finance/Rental/LeasingFinance TPG Special Situations Partners LLC provides financial services. The company is headquartered in Fort Worth, TX. | Finance |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Oren Isacoff
